Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Terminated 1 Completed 1

Sponsor Class

INDUSTRY 5 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Ovarian Epithelial 1

Interventions

Cyclophosphamide 241 Radiotherapy 217 Gemcitabine 187 Cisplatin 185 Carboplatin 182 Docetaxel 166 Bevacizumab 166 Paclitaxel 144 Capecitabine 142 Rituximab 141 pembrolizumab 140 Nivolumab 126 Oxaliplatin 124 Dexamethasone 122 Fluorouracil 113 fludarabine 104 Radiosurgery 101 Doxorubicin 99 fludarabine phosphate 97 Irinotecan 96 Etoposide 95 Lenalidomide 93 Cytarabine 92 Magnetic Resonance Spectroscopy 90 Radiation 89 Filgrastim 89 Leucovorin 88 Bortezomib 86 Cetuximab 80 Pemetrexed 79

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × OTHER × oregovomab × Clear all

NCT03100006 2022-06-13

ORION-01

National Cancer Centre, Singapore

Phase 1/2 Terminated

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡